13.90
+0.21(+1.53%)
Currency In USD
| Previous Close | 13.69 |
| Open | 13.62 |
| Day High | 14 |
| Day Low | 13.62 |
| 52-Week High | 21.48 |
| 52-Week Low | 9.2 |
| Volume | 364,174 |
| Average Volume | 605,144 |
| Market Cap | 812.94M |
| PE | 9.79 |
| EPS | 1.42 |
| Moving Average 50 Days | 13.18 |
| Moving Average 200 Days | 13.81 |
| Change | 0.21 |
If you invested $1000 in Embecta Corp. (EMBC) since IPO date, it would be worth $319.54 as of September 29, 2025 at a share price of $13.9. Whereas If you bought $1000 worth of Embecta Corp. (EMBC) shares 2 years ago, it would be worth $969.32 as of September 29, 2025 at a share price of $13.9.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
embecta to Report Fiscal Third Quarter 2025 Financial Results
GlobeNewswire Inc.
Jul 24, 2025 9:00 PM GMT
PARSIPPANY, N.J., July 24, 2025 (GLOBE NEWSWIRE) -- Embecta Corp. (“embecta”) (Nasdaq: EMBC), a global company that is advancing its 100-year legacy in insulin delivery to become a broad-based medical supplies company, will host a conference call t
embecta to Participate in Investor Events
GlobeNewswire Inc.
May 27, 2025 9:00 PM GMT
PARSIPPANY, N.J., May 27, 2025 (GLOBE NEWSWIRE) -- Embecta Corp. ("embecta") (Nasdaq: EMBC), a global company that is advancing its 100-year legacy in insulin delivery to become a broad-based medical supplies company, today announced that managemen
embecta to Showcase Phased Approach for Value Creation and Present Long Range Financial Plan at 2025 Analyst and Investor Day
GlobeNewswire Inc.
May 22, 2025 10:30 AM GMT
PARSIPPANY, N.J., May 22, 2025 (GLOBE NEWSWIRE) -- Embecta Corp. ("embecta"; "The Company") (Nasdaq: EMBC), a global diabetes care company with a 100-year legacy in insulin delivery, will host its inaugural Analyst and Investor Day today to showcas